花青3胺 (Cyanine3 amine)
貨號 | 數量 | 價格 | 交貨時間 | 購買此產品 |
---|---|---|---|---|
110C0 | 1 mg | $125 | 現貨 | |
210C0 | 5 mg | $260 | 現貨 | |
410C0 | 25 mg | $510 | 現貨 | |
510C0 | 50 mg | $895 | 現貨 | |
610C0 | 100 mg | $1490 | 現貨 |
顧客還購買了這個產品
菁染料5 DBCO (Cyanine5 DBCO)
Cyanine5 染料具有二苯並環辛炔 (DBCO) 官能團,用於無銅條件的連結化學。Cyanine3 NHS酯
胺反應性 Cyanine3 染料 NHS 酯。FAM 炔烴,6-異構體
用於點擊化學偶聯中的螢光素染料炔烴,純 6-異構體。外观: | |
分子量: | 627.73 |
CAS 编号: | 2247688-56-6 |
分子式: | C36H52Cl2N4O |
IUPAC 名称: | 3H-Indolium, 1-[6-[(6-aminohexyl)amino]-6-oxohexyl]-2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propen-1-yl]-3,3-dimethyl-, chloride, hydrochloride (1:1:1) |
溶解度: | |
质量控制: | |
储存条件: | |
MSDS: | 下載 |
產品規格 |
激发/吸收极大值,纳米: | 555 |
ε, 摩尔吸光系数,cm⁻¹: | 150000 |
发射极大值,纳米: | 570 |
荧光量子产率: | 0.31 |
CF260: | 0.04 |
CF280: | 0.09 |
產品引用
- Gorshkova, M.; Vanchugova, L.; Osipova, N.; Nikitin, A.; Kotova, J.; Kovalenko, E.; Ermolenko, Y.; Malinovskaya, J.; Kovshova, T.; Gelperina, S. Hybrid DIVEMA/PLGA nanoparticles as the potential drug delivery system. Research Square, 2024, preprint. doi: 10.21203/rs.3.rs-4594368/v1
- Ruan, Z.; Li, S.; Grigoropoulos, A.; Amiri, H.; Hilburg, S. L.; Chen, H.; Jayapurna, I.; Jiang, T.; Gu, Z.; Alexander-Katz, A.; Bustamante, C.; Huang, H.; Xu, T. Population-Based Heteropolymer Design to Mimic Protein Mixtures. Nature, 2023, 615(7951), 251–258. doi: 10.1038/s41586-022-05675-0
- Nizamov, T. R.; Iliasov, A. R.; Vodopyanov, S. S.; Kozhina, I. V.; Bordyuzhin, I. G.; Zhukov, D. G.; Ivanova, A. V.; Permyakova, E. S.; Mogilnikov, P. S.; Vishnevskiy, D. A.; Shchetinin, I. V.; Abakumov, M. A.; Savchenko, A. G. Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. Pharmaceutics, 2023, 15(1), 127. doi: 10.3390/pharmaceutics15010127
- Malinovskaya, J.; Salami, R.; Valikhov, M.; Vadekhina, V.; Semyonkin, A.; Semkina, A.; Abakumov, M.; Harel, Y.; Levy, E.; Levin, T.; Persky, R.; Chekhonin, V.; Lellouche, J.-P.; Melnikov, P.; Gelperina, S. Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy. International Journal of Molecular Sciences, 2023, 24(1), 627. doi: 10.3390/ijms24010627
物品數量不正確.